Clinical Trial Update: Trial of DA-EPOCH Regimen for NHL With HLH [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the DA-EPOCH regimen for non-Hodgkin lymphoma with hemophagocytic lymphohistiocytosis; the current status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: NHL With Hemophagocytic Lymphohistiocytosis | Phase 2 | Status: UNKNOWN